Avidity Biosciences Inc Live Share Price Today, Share Analysis and Chart

Name: Avidity Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Avidity Biosciences Inc
Rating: 1.31008325
Author: Trendlyne DVM scores

about

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical...

34.25 2.80 (8.90%)

38.84% Fall from 52W High

982.8K

XNAS Volume

XNAS 14 Jul, 2025 9:51 AM (EDT)

Not Eligible

Expensive Valuation

7.8 / 100

Technically Neutral

44.6 / 100

1Yr Price target upside is 94%

18 analysts

Avidity Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Avidity Biosciences Inc Live Share Price Today, Share Analysis and Chart

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical...

38.84% Fall from 52W High

SWOT Analysis

Avidity Biosciences Inc Live Price Chart